Incremental Value of CSF Biomarkers in Clinically Diagnosed AD and Non-AD Dementia

Frontiers in Neurology
Jean-Baptiste OudartRachid Mahmoudi

Abstract

Background: Cerebrospinal fluid (CSF) biomarkers are used to diagnose Alzheimer disease (AD), especially in atypical clinical presentations. No consensus currently exists regarding cut-off values. This study aimed, firstly, to define optimal cut-off values for CSF biomarkers, and secondly, to investigate the most relevant diagnostic strategy for AD based on CSF biomarker combinations. Methods: A total of 380 patients were prospectively included: 140 with AD, 240 with various neurological diagnoses (non-AD). CSF biomarkers were measured using ELISA. Univariate and multivariate analyses were performed using random forest and logistic regression approaches. Results: Univariate receiver operating curve curves analysis of T-Tau, P-Tau181, Aβ42, Aβ40 concentrations, and Aβ42/Aβ40 ratio levels showed AD cut-off values of ≥355, ≥57, ≤706, ≥10,854, and ≤0.059 ng/L, respectively. Multivariate analysis using random forest and logistic regression found that the algorithm based on P-Tau181, Aβ42 concentrations and Aβ42/Aβ40 ratio yielded the best discrimination between AD and non-AD populations. The cross-validation technique of the final model showed a mean accuracy of 0.85 and a mean AUC of 0.89. Conclusion: This study confirms that the A...Continue Reading

References

Oct 21, 2005·Neurology·I G McKeithUNKNOWN Consortium on DLB
May 29, 2009·The New England Journal of Medicine·George M SavvaUNKNOWN Medical Research Council Cognitive Function and Ageing Study
Mar 6, 2010·Acta Neuropathologica·Kurt A Jellinger, Johannes Attems
Aug 4, 2011·Brain : a Journal of Neurology·Katya RascovskyBruce L Miller
Oct 16, 2012·Current Alzheimer Research·Stéphanie BomboisSusanna Schraen-Maschke
Oct 31, 2012·Annals of Neurology·David A BennettJulie A Schneider
May 15, 2013·Journal of Alzheimer's Disease : JAD·Sylvie SlaetsSebastiaan Engelborghs
Nov 21, 2013·British Journal of Clinical Pharmacology·Zoubir DjeradaJean-Marc Malinovsky
May 23, 2014·Lancet Neurology·Bruno DuboisJeffrey L Cummings
Aug 26, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·José Luis MolinuevoLucilla Parnetti
Dec 9, 2014·Medical Image Computing and Computer-assisted Intervention : MICCAI·Tiancheng HeStephen T Wong
Mar 26, 2015·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Michael EwersHarald Hampel
Jun 3, 2015·Alzheimer's Research & Therapy·Julien DumurgierSylvain Lehmann
Feb 28, 2016·Lancet·Philip ScheltensWiesje Maria Van der Flier
Jan 6, 2017·Neuropathology and Applied Neurobiology·H Zetterberg
Feb 15, 2017·Alzheimer's Research & Therapy·Daniela BertensPieter Jelle Visser
Mar 21, 2017·Neurobiology of Aging·Niklas MattssonUNKNOWN Geneva Task Force for the Roadmap of Alzheimer's Biomarkers
Jul 21, 2017·Frontiers in Neurology·Linda J C van Waalwijk van DoornCharlotte E Teunissen
Sep 5, 2017·Journal of Alzheimer's Disease : JAD·Ellis NiemantsverdrietSebastiaan Engelborghs
Dec 14, 2017·Clinical Pharmacokinetics·Zoubir DjeradaJean-Marc Malinovsky
Jan 13, 2018·Journal of Neurology, Neurosurgery, and Psychiatry·Olivier BousigesUNKNOWN ePLM network and collaborators
Jan 27, 2018·Biomarker Insights·Peter J MazzoneVictoria Doseeva
Apr 15, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Clifford R JackUNKNOWN Contributors
May 10, 2018·Disease Models & Mechanisms·Tammaryn LashleyHenrik Zetterberg
May 1, 2019·Brain : a Journal of Neurology·Peter T NelsonJulie A Schneider

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
ELISAs
protein assay

Software Mentioned

tune Ranger
R
random Forest package R

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.